Medical Affairs Uptick
PharmExec
DECEMBER 8, 2022
Experts in attendance at Pharma 2022 share insights on medical affairs.
PharmExec
DECEMBER 8, 2022
Experts in attendance at Pharma 2022 share insights on medical affairs.
Impetus Digital
JANUARY 13, 2023
Medical Affairs evolving and embracing digital transformation. Medical Affairs will continue evolving. A recent McKinsey & Company report titled A vision for Medical Affairs in 2025 provides fantastic insights into the evolution of Medical Affairs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
AUGUST 9, 2022
Medical Affairs, Eli Lilly, told FiercePharma. While pharma has seen a serious uptick in recent migraine treatment and services, this type of stigma can be an obstacle in patients’ treatment and well-being. Spectral Medical Inc. FDA Update. Drug Approvals. Med Device Approvals.
Clarify Health
JULY 13, 2020
The panel included Bhash Parasuraman, PhD, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer , Calum MacRae, MD, PhD, Professor of Medicine at Harvard Medical School , and Surya Singh, MD, President, Singh Healthcare Advisors. Despite this uptick, revenue per drug has declined. Take Zolgensma, for example.
Let's personalize your content